Access to Medication: An Advocacy Resource List
A resource list for state advocates working on access to medications. Includes information on the CATIE and CUTLAS studies; the experiences of individual states; and Medicaid.
Partnership for Prescription Assistance
A new toll-free number and Web site provide help to those who lack prescription coverage or cannot afford their medications.
CMS Advises Against Restricting Access to Medications
On August 20, 2004, the Centers for Medicare and Medicaid Services (CMS) issued a Technical Assistance Paper -"Psychotropic Medications: Addressing Costs without Restricting Access." CMS supports several state efforts to control the escalation in prescription drug costs while maintaining access to newer, effective medications.
NAMI Policy Research Institute
Learn more about NAMI's Policy Research Institute, whose mission is to drive national, state, and local debates on reforms and investments in the nation's mental illness delivery and financing system.
Mental Health Services Locator
A state-by-state database of comprehensive information about mental health services and resources. Useful for professionals, consumers and their families, and the public. (source: SAMHSA/CMHS)
The Risks of Cost-Sharing
Recent studies find that increasing cost-shairng for health benefits may result in decreased compliance with drug regimens. This may have negative consequences long-term.
Texas Medication Algorithm Project (TMAP)
TMAP, started in 1996, is designed to develop, implement and evaluate not just a set of medication algorithms, but an algorithm-driven treatment philosophy for major adult psychiatric disorders treated in the Texas public mental health sector.
Kaiser Family Foundation
Provides information and analysis on a broad range of policy issues, emphasizing those that most affect low-income and vulnerable populations. Major initiatives and focus areas include the Kaiser Commission on Medicaid and the Uninsured and the Medicare Policy Project.
President's New Freedom Commission on Mental Health
A report from the Policy Options Subcommittee on Evidence-Based Practices on Mental Health Policy and Psychotropic Drugs, February 6, 2003